Quinapril (Ranbaxy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Quinapril drug offered from Ranbaxy Pharmaceuticals Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | quinapril |
| SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2007-09-24 |
| END MARKETING DATE: | 0000-00-00 |
Quinapril HUMAN PRESCRIPTION DRUG Details:
| Item Description | Quinapril from Ranbaxy Pharmaceuticals Inc. |
| LABELER NAME: | Ranbaxy Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2007-09-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63304-548_fbea9a22-e8f7-43c6-9a85-9e49aef6affd |
| PRODUCT NDC: | 63304-548 |
| APPLICATION NUMBER: | ANDA076607 |
Other QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
